Diagnostic Nanoprobes and Imaging Agents

The introduction of nanotechnology has enabled the development of highly sensitive and targeted diagnostic nanoprobes and imaging agents, transforming the field of medical diagnostics. The ability to precisely monitor and detect diseases early on has been difficult, and these nanoscale systems have brought about revolutionary changes in traditional diagnostic techniques. This chapter looks at the development, synthesis, and use of imaging agents and diagnostic nanoprobes, emphasizing theranostics and digital healthcare. We explored several kinds of nanoprobes, composed of gold, silver, magnetic, carbon, quantum dots, polymers, and lipids, highlighting their special optical, electrical, and magnetic characteristics that make them ideal for biomedical imaging. We also discussed the integration of these nanoprobes with cutting-edge imaging modalities such as fluorescence imaging, MRI, and PET, enabling the real-time and high-resolution visualization of disease biomarkers at the molecular level. The focus is on the development of smart and sustainable nanomaterials that improve the safety and efficacy of diagnostic processes while simultaneously tackling the issues of toxicity, biocompatibility, and environmental impact. This chapter intends to contribute to the continuing evolution of digital healthcare and theranostic approaches by offering a thorough overview of the recent developments and potential future developments in diagnostic nanoprobes and imaging agents. In the long run, this will improve patient outcomes and support sustainable healthcare practices.